19,721 Danaher Corporation $DHR Shares Bought by Jackson Square Capital LLC

Jackson Square Capital LLC boosted its holdings in Danaher Corporation (NYSE:DHR) by 213.0% in the third quarter, according to its most recent filing with the SEC. The institutional investor owned 28,981 shares of the conglomerate’s stock after buying an additional 19,721 shares during the period. Danaher accounts for approximately 1.0% of Jackson Square Capital LLC’s holdings, making the stock its 28th biggest position. Jackson Square Capital LLC’s holdings in Danaher were worth $6,421,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also bought and sold shares of the business. First Bank & Trust raised its position in shares of Danaher by 36.9% during the third quarter. First Bank & Trust now owns 1,939 shares of the conglomerate’s stock valued at $430,000 after buying an additional 523 shares during the last quarter. Clark Wealth Partners lifted its holdings in shares of Danaher by 7,451.6% in the third quarter. Clark Wealth Partners now owns 2,341 shares of the conglomerate’s stock worth $520,000 after buying an additional 2,310 shares in the last quarter. Brown Lisle Cummings Inc. boosted its position in shares of Danaher by 219.1% during the third quarter. Brown Lisle Cummings Inc. now owns 4,059 shares of the conglomerate’s stock worth $899,000 after acquiring an additional 2,787 shares during the last quarter. Ardent Capital Management Inc. bought a new position in shares of Danaher during the third quarter worth $587,000. Finally, SteelPeak Wealth LLC grew its stake in Danaher by 239.4% during the third quarter. SteelPeak Wealth LLC now owns 6,707 shares of the conglomerate’s stock valued at $1,486,000 after acquiring an additional 4,731 shares in the last quarter. 79.05% of the stock is owned by institutional investors.

Danaher Price Performance

Shares of NYSE DHR traded down $4.12 during midday trading on Monday, reaching $224.91. 1,511,911 shares of the stock traded hands, compared to its average volume of 4,440,547. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.65 and a quick ratio of 1.25. The stock has a market capitalization of $158.11 billion, a PE ratio of 39.94, a P/E/G ratio of 2.88 and a beta of 0.76. Danaher Corporation has a one year low of $160.93 and a one year high of $242.80. The company’s 50 day moving average is $214.04 and its 200 day moving average is $196.06.

Danaher (NYSE:DHR) last posted its earnings results on Monday, July 20th. The conglomerate reported $1.94 earnings per share for the quarter, beating analysts’ consensus estimates of $1.85 by $0.09. The firm had revenue of $6.26 billion during the quarter, compared to analyst estimates of $6.12 billion. Danaher had a net margin of 15.95% and a return on equity of 11.04%. Danaher’s revenue for the quarter was up 5.5% compared to the same quarter last year. During the same period last year, the firm posted $0.77 earnings per share. On average, equities research analysts anticipate that Danaher Corporation will post 8.53 earnings per share for the current year.

Danaher Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, October 30th. Shareholders of record on Wednesday, September 30th will be paid a $0.40 dividend. This represents a $1.60 dividend on an annualized basis and a dividend yield of 0.7%. The ex-dividend date of this dividend is Wednesday, September 30th. Danaher’s dividend payout ratio (DPR) is presently 28.42%.

Analyst Ratings Changes

A number of analysts have issued reports on the stock. Barclays lifted their price target on shares of Danaher from $230.00 to $255.00 and gave the company an “overweight” rating in a report on Wednesday, October 7th. Evercore reissued an “outperform” rating and set a $230.00 price objective on shares of Danaher in a report on Monday, July 6th. Morgan Stanley raised their price objective on Danaher from $220.00 to $240.00 and gave the company an “overweight” rating in a research report on Monday, October 12th. Royal Bank Of Canada raised their price objective on Danaher from $215.00 to $250.00 and gave the company an “outperform” rating in a research report on Monday, October 5th. Finally, Weiss Ratings raised Danaher from a “hold (c-)” rating to a “hold (c)” rating in a report on Wednesday, September 16th. Two analysts have rated the stock with a Strong Buy rating, seventeen have issued a Buy rating and four have assigned a Hold rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $235.41.

About Danaher

Danaher Corporation (NYSE: DHR) is a global science and technology company that develops products, services and solutions for the life sciences, biotechnology and diagnostics markets. Its offerings help researchers, pharmaceutical and biotechnology companies, healthcare providers and other organizations conduct scientific research, develop and manufacture medicines, and diagnose disease.

The company operates through businesses that provide bioprocessing equipment and technologies, laboratory instruments, consumables, analytical tools and clinical diagnostic systems.